Compile Data Set for Download or QSAR
Report error Found 476 Enz. Inhib. hit(s) with all data for entry = 13044
TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754501BDBM754501(1-(5-cyanopyridin-2-yl)-N-(2-(difluoromethoxy)-6-m...)
Affinity DataIC50: 1nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754489BDBM754489(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(4-...)
Affinity DataIC50: 1nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754300BDBM754300(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(2-...)
Affinity DataIC50: 1.30nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754419BDBM754419(1-(2-(3-((2-(difluoromethoxy)-6-methylpyridin-3-yl...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754483BDBM754483(methyl 1-(5-(3-((2-(difluoromethoxy)-6-methylpyrid...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754495BDBM754495(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(5-...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754637BDBM754637(1-(2-(1H-tetrazol-1-yl)acetyl)-N-(2-(difluorometho...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754492BDBM754492(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(3-...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754507BDBM754507(1-(5-cyanopyrimidin-2-yl)-N-(2-(difluoromethoxy)-6...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754699BDBM754699(N-(5-bromo-3-(difluoromethoxy)pyridin-2-yl)-3-(2-i...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754696BDBM754696(N-(5-chloro-3-(difluoromethoxy)pyridin-2-yl)-3-(2-...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754327BDBM754327(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(2-...)
Affinity DataIC50: 2nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754709BDBM754709(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(3-...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754317BDBM754317((R)-N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754347BDBM754347(ethyl-3-(4-((2-(difluoromethoxy)-6-methylpyridin-3...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754714BDBM754714(N3-(5-bromo-3-(difluoromethoxy)pyridin-2-yl)-N1-cy...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754537BDBM754537(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(2-...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754711BDBM754711(N3-(5-chloro-3-(difluoromethoxy)pyridin-2-yl)-N1-c...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754534BDBM754534(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(5-...)
Affinity DataIC50: 3nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754309BDBM754309(N-(6-ethoxy-2-methoxypyridin-3-yl)-3-(2-isopropylp...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754340BDBM754340(1-(2-cyanoethyl)-N-(2-(difluoromethoxy)-6-methylpy...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754306BDBM754306(N-(2,6-dimethoxypyridin-3-yl)-3-(2-isopropylphenyl...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754546BDBM754546(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(2-...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754658BDBM754658(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(2-...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754273BDBM754273(3-((3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)c...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754593BDBM754593(3-((3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)c...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754368BDBM754368(methyl 4-(4-((2-(difluoromethoxy)-6-methylpyridin-...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754378BDBM754378(methyl (3-((2-(difluoromethoxy)-6-methylpyridin-3-...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754504BDBM754504(1-(5-cyanopyridin-2-yl)-N-(2-(difluoromethoxy)pyri...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754614BDBM754614(3-((3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)c...)
Affinity DataIC50: 4nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754674BDBM754674(2-((4-((2-(difluoromethoxy)-6-methylpyridin-3-yl)c...)
Affinity DataIC50: 4.30nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754523BDBM754523(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(2-...)
Affinity DataIC50: 4.60nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754304BDBM754304(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(3-...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754633BDBM754633(4-(3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)ca...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754279BDBM754279(1-(((3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754325BDBM754325(1-(2-aminopropyl)-N-(2-(difluoromethoxy)-6-methylp...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754708BDBM754708(N-(5-chloro-3-(difluoromethoxy)pyridin-2-yl)-3-(3-...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754417BDBM754417(2-(4-((2-(difluoromethoxy)-6-methylpyridin-3-yl)ca...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754288BDBM754288(Ethyl ((3-((2-(difluoromethoxy)-6-methylpyridin-3-...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754416BDBM754416(1-(2-(3-((2-(difluoromethoxy)-6-methylpyridin-3-yl...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754510BDBM754510(1-(5-cyanopyrimidin-2-yl)-N-(2-(difluoromethoxy)py...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754588BDBM754588(4-(3-(2-cyclopentylphenyl)-3-((2-(difluoromethoxy)...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754298BDBM754298(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-1-(2-...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754425BDBM754425(4-(3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)ca...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754424BDBM754424(5-((3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)c...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754423BDBM754423(methyl (3-((2-(difluoromethoxy)-6-methylpyridin-3-...)
Affinity DataIC50: 5nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754640BDBM754640(1-(2-(2H-1,2,3-triazol-2-yl)acetyl)-N-(2-(difluoro...)
Affinity DataIC50: 5.60nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754677BDBM754677(2-((4-((2-(difluoromethoxy)-6-methylpyridin-3-yl)c...)
Affinity DataIC50: 6nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754403BDBM754403(methyl 4-((3-((2-(difluoromethoxy)-6-methylpyridin...)
Affinity DataIC50: 6nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 754352BDBM754352(N-(2-(difluoromethoxy)-6-methylpyridin-3-yl)-3-(2-...)
Affinity DataIC50: 6nMAssay Description:The Tango™ EDG2-bla U2OS cells are obtained from Invitrogen. These cells contain the human LPA1 receptor cDNA linked to a TEV protease site and a Gal...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

Displayed 1 to 50 (of 476 total ) | Next | Last >>
Jump to: